Glioma Cells
Original Article A high-throughput drug screen for identifying NF-κB inhibitors to suppress proliferation of malignant brain glioma cells
9
RasGRP3 regulates the migration of glioma cells via interaction with Arp3
15
Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL
10
Original Article Silencing of TIPE3 suppresses proliferation of human glioma cells via AKT signaling pathway
7
Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal
16
Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo
14
ERN1 knockdown modifies the hypoxic regulation of TP53, MDM2, USP7 and PERP gene expressions in U87 glioma cells
13
MAGI3 negatively regulates Wnt/ -catenin signaling and suppresses malignant phenotypes of glioma cells
15
Local Glioma Cells Are Associated with Vascular Dysregulation
8
Histone deacetylase 6 inhibition enhances oncolytic viral replication in glioma
13
Circadian genes Per1 and Per2 increase radiosensitivity of glioma in vivo
8
Original Article Berberine inhibits cell growth via Wnt/beta-catenin signaling in glioma
6
Comparative Biology of Glioma Stem Cells and Embryonic Neural Stem Cells in Dogs.
294
Interferon-regulatory factor-1 (IRF1) regulates bevacizumab induced autophagy
14
Glioma stem cells-derived exosomal miR-26a promotes angiogenesis of microvessel endothelial cells in glioma
15
Targeted therapy for glioma using cyclic RGD-entrapped polyionic complex nanomicelles
10
Glioma Stem Cell Targeted Dendritic Cells as a Tumor Vaccine Against Malignant Glioma
9
Original Article miR-423-5p inhibits the proliferation and metastasis of glioblastoma cells by targeting phospholipase C beta 1
10
Disruption of the EZH2/miRNA/β-catenin signaling suppresses aerobic glycolysis in glioma
9
LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4
11